Skip to main content
. Author manuscript; available in PMC: 2012 Jan 1.
Published in final edited form as: Stroke. 2010 Dec 2;42(1):2–9. doi: 10.1161/STROKEAHA.110.591230

Table 3.

Haplotype analyses for Lp(a) and CAAD.

Trait SNPs High risk haplotypes(s)* Frequency Lp(a) β or CAAD OR P-value (Lp(a) % variance)
Lp(a) rs3798221/rs10455872 GA 0.017 1.8 1.3 × 10−76 (21%)
AG 0.076 1.8
Lp(a) rs6919346/rs3798221/rs10455872 GGA 0.017 2.1 5.0 × 10−82 (23%)
GAG 0.075 2.1
GAA 0.75 0.42
Lp(a) rs6919346/rs3798220/rs10455872/rs2295368 GAAA 0.34 0.62 4.1 × 10−12 (25%)
Lp(a) rs6919346/rs3798220/rs3798221/rs10455872/rs2295368 GACAA 0.27 0.94 8.3 × 10−18 (25%)
CAAD rs6919346/rs10455872 GG 0.075 2.0 0.020
CAAD rs3123629/rs6919346/rs10455872 AGG 0.066 2.1 0.054

Haplotype analyses were performed using covariates as described in Methods.

*

Haplotypes among the set tested with the largest β for Lp(a) or OR for CAAD.

P-values are for the global test of no difference between haplotypes versus any differences and are Bonferroni corrected for the number of haplotypes tested.

Conditional on the major allele (AA) background of rs3798220 and rs10455872.